Selection Panel

Patrick Hines

Founder and CEO, Functional Fluidics

North America

Patrick Hines, an Associate Professor of Pediatric Critical Care Medicine at the Children’s Hospital of Michigan, developed a clinical bioassay for measuring red blood cell function during simulated blood flow in his Wayne State University research laboratory. He was inspired by the critically ill children he cares for in the cardiac intensive care unit to make this technology available to patients and providers worldwide. He founded Functional Fluidics in 2014 to further develop and market specialized blood-based bioassays with the potential to identify patients at risk for blood flow abnormalities, facilitate early intervention and reduce the rising cost of health care by targeting the right therapy to the right patient, at the right time. Functional Fluidics’ blood function bioassays are regarded as the “gold standard,” as demonstrated by their wide adoption by pharmaceutical companies developing sickle cell disease therapies, including Pfizer, Novartis, Global Blood Therapeutics, Gilead, Imara, Modus, Prolong, Sancillio, Biogen, Bioverativ, Agios, Hemenext and more. These bioassays are currently being evaluated for applications in perinatology, diabetes, transfusion medicine and surgical bleeding. In recognition of this work, Dr. Hines was selected as a Health Innovation Fellow within the Aspen Global Leadership Network and is a Crain’s Detroit

Return to Experts